Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000318306-07-000031
Filing Date
2007-05-15
Accepted
2007-05-15 16:43:38
Documents
10
Period of Report
2007-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 10QSB form10qsb33107.htm 10QSB 492725
2 2007 SPECIAL STOCK OPTION PLAN ex_10-35.htm EX-10.35 54040
3 EMPLOYEMENT AGREEMENT - CEO SEILER ex_10-36.htm EX-10.36 84262
4 AMENDMENT TO ORACLE AND AFFILIATES NOTES ex_10-37.htm EX-10.37 23409
5 AMENDMENT TO SCO AND AFFILIATES NOTES ex_10-38.htm EX-10.38 126643
6 AMENDMENT TO INVESTOR RIGHTS AGREEMENT ex_10-39.htm EX-10.39 21989
7 CEO CERTIFICATION ex_31-1.htm EX-31.1 17326
8 CFO CERTIFICATION ex_31-2.htm EX-31.2 17807
9 CEO CERTIFICATION ex_32-1.htm EX-32.1 6830
10 CFO CERTIFICATION ex_32-2.htm EX-32.2 5877
  Complete submission text file 0000318306-07-000031.txt   852531
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 001-15771 | Film No.: 07854077
SIC: 2834 Pharmaceutical Preparations